Deal type reports
-
Distribution Deals in Diagnostics 2016-2026September 2026$3,995.00Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Learn More -
Licensing Deals in Biotechnology 2020-2026September 2026$4,995.00Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2026
Learn More -
Collaboration Deals in Biotechnology 2021-2026September 2026$3,995.00Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2021 to 2026
Learn More -
Distribution Deals in Medical Devices 2016-2026September 2026$3,995.00Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Learn More -
Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2021-2026September 2026$3,995.00Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2021 to 2026
Learn More -
Collaboration Deals in Pharmaceuticals 2021-2026September 2026$3,995.00Collaboration Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2021 to 2026
Learn More -
Custom Executive Partnering BriefingSeptember 2026$0.00Custom Executive Partnering Briefings apply Current Partnering’s proprietary pharma and biotech deal intelligence to your company, pipeline or strategic priorities. Each briefing delivers focused analysis of relevant deals, potential partners, financial benchmarks and market trends. Standalone briefings start from USD$3,995 with a free proposed table of contents and scope available on request.
Learn More
